冠心病组与对照组血清去氢表雄酮、去氢表雄酮硫酸酯及雌二醇水平无显著性差异（均P>0.05）。
No obvious difference in DHEA, DHEAS and E2 level was found between two groups(all P>0.05).
进一步研究将探究潜在的去氢表雄酮替代疗法和改变延时释放氢化可的松，从而提高肾上腺功能不全患者的治疗效果。
Future studies will have to explore the potential of dehydroepiandrosterone replacement and modified delayed-release hydrocortisone to improve the prospects of patients with adrenal insufficiency.
进一步研究将探究潜在的去氢表雄酮替代疗法和改变延时释放氢化可的松，从而提高肾上腺功能不全患者的治疗效果。
Future studies will have to explore the potential of dehydroepiandrosterone replacement and modified delayed-release hydrocortisone to improve the prospects of patients with adrenal insufficiency.
应用推荐